← Open Payments lookup

JERRI BRACEY: Open Payments

NPI 1023625688 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,169 in 81 payments from 16 companies in 2025. Trend: 2023 $211 · 2024 $868 · 2025 $2,169

Food & beverage: $2,169
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.8$441
Otsuka America Pharmaceutical, Inc.19$419
ABBVIE INC.10$363
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$236
Janssen Pharmaceuticals, Inc5$115
Teva Pharmaceuticals USA, Inc.4$103
Takeda Pharmaceuticals U.S.A., Inc.4$98
Axsome Therapeutics, Inc.4$88
Alkermes, Inc.3$72
Lundbeck LLC3$56

Products named: INGREZZA, REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, TRINTELLIX, Auvelity, AUSTEDO XR.

Industry payments across NV — which companies pay providers there.